A Pilot Study on the Feasibility Study of a Novel Virtual Reality (VR)-Based Post-stroke Hemineglect Evaluation System
NCT ID: NCT05145699
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
43 participants
INTERVENTIONAL
2021-08-31
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring Stroke Patients With Near-infrared Spectroscopy Before, During and After Endovascular Treatment
NCT03738644
Formation of Health Professionals Through in Situ Simulation to Improve Performances During the Initial Step of Thrombectomy for Ischemic Strokes
NCT03738371
The Neuroprotective Effect of Remote Ischemic Preconditioning on Ischemic Cerebral Vascular Disease
NCT01321749
Cerebral Hemodynamics During Early Verticalization After (Successful) Thrombectomy Poststroke
NCT04573114
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
NCT03268668
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The normal value for each item is determined based on the result value for each item of the virtual reality (VR)-based hemineglect evaluation system in normal people.
It is checked whether there is a difference in the results measured using the VR-based hemineglect evaluation system in normal persons, stroke patients with hemineglect, and stroke patients without hemineglect.
Structural validity is confirmed by examining the correlation between the measured values of the virtual VR-based hemineglect evaluation system and Korean Version of Modified Barthel Index (K-MBI), Mini Mental State Examination (MMSE), and Behavioral Inattention Test-Conventional (BIT-C) in stroke patients with hemineglect.
Check the required time and test stability of the evaluation using the VR-based hemineglect evaluation system.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Right hemispheric stroke with hemineglect
VR-based post-stroke hemineglect evaluation system
Evaluation system applied with virtual environment using Pico Neo 2 eye
Right hemispheric stroke without hemineglect
VR-based post-stroke hemineglect evaluation system
Evaluation system applied with virtual environment using Pico Neo 2 eye
Normal people
VR-based post-stroke hemineglect evaluation system
Evaluation system applied with virtual environment using Pico Neo 2 eye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR-based post-stroke hemineglect evaluation system
Evaluation system applied with virtual environment using Pico Neo 2 eye
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right handed
* Patients with first onset stroke, with right brain lesions confirmed by imaging tests (MRI, CT)
* Onset of stroke more than 1week (Normal people)
* Right handed
* Who has no problem in identifying objects with wearing VR head gear.
Exclusion Criteria
* Patients with unilateral neglect due to other causes.
* Patients with neurological diseases other than stroke (Parkinson's disease, Alzheimer's disease, etc.)
* Patients with severe cognitive impairment.
* Patients with underlying diseases or medical history that may cause visual impairment.
(Normal people)
* Who has a neurological disease such as stroke, traumatic brain injury, Parkinson's disease, or Alzheimer's disease.
* Who has a severe cognitive impairment.
* Who has a underlying diseases or medical history that may cause visual impairment.
19 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nam-Jong Paik
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nam-Jong Paik, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Bundang Hospital, Seongnam, South Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2108-705-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.